Entropy Technologies »

Zentalis Pharmaceuticals shares owned by Entropy Technologies

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Entropy Technologies from 13F filings

Historical chart of Entropy Technologies investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Entropy Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Entropy Technologies

Quarter filed Position value Share count Share price at filing
2023-12-31 $613k 40k 15.15

More positions owned by Entropy Technologies

Constellation Brands Cl A (STZ)
Schlumberger Com Stk (SLB)
FactSet Research Systems (FDS)
Marathon Oil Corporation (MRO)
Humana (HUM)
Accenture Plc Ireland Shs Class A (ACN)
Monday SHS (MNDY)
Fox Corp Cl A Com (FOXA)
Zscaler Incorporated (ZS)
M&T Bank Corporation (MTB)
Shift4 Pmts Cl A (FOUR)
Cintas Corporation (CTAS)
ResMed (RMD)
Intel Corporation (INTC)
Advanced Micro Devices (AMD)

View all positions for Entropy Technologies

Top funds holding Zentalis Pharmaceuticals

Eventide Asset Management
Vanguard Group
Citadel Advisors
T. Rowe Price Associates
Federated Investors
Decheng Capital
PRIMECAP Management Company
Dimensional Fund Advisors
Bank of America Corporation
Logos Global Management
5AM Venture Management
Caption Management
Boxer Capital
Charles Schwab Investment Management
Paradigm Biocapital Advisors

View all funds holding Zentalis Pharmaceuticals